{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:20:31Z","timestamp":1778430031977,"version":"3.51.4"},"reference-count":22,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24027","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T22:14:59Z","timestamp":1719440099000},"page":"138-143","source":"Crossref","is-referenced-by-count":2,"title":["T-cell receptor gamma gene rearrangement analysis of classic Hodgkin lymphoma using a BIOMED-2 assay: a paraffin-embedded tissue analysis of one hundred cases"],"prefix":"10.3960","volume":"64","author":[{"given":"Katsuyoshi","family":"Takata","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Pathology, Niigata University Graduate School of Medicine, Niigata, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Miyata-Takata","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Pathology, Niigata University Graduate School of Medicine, Niigata, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoka","family":"Haratake","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Piccaluga PP, Agostinelli C, Gazzola A <i>et al.<\/i> Pathobiology of hodgkin lymphoma. Adv Hematol. 2011; 2011: 920898.","DOI":"10.1155\/2011\/920898"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Steidl C, Connors JM, Gascoyne RD. Molecular pathogenesis of Hodgkin\u2019s lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol. 2011; 29: 1812-1826.","DOI":"10.1200\/JCO.2010.32.8401"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Aoki T, Chong LC, Takata K <i>et al.<\/i> Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. Cancer Discov. 2020; 10: 406-421.","DOI":"10.1158\/2159-8290.CD-19-0680"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Alaggio R, Amador C, Anagnostopoulos I, <i>et al.<\/i> The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022; 36: 1720-1748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Knowles DM 2nd, Neri A, Pelicci PG <i>et al.<\/i> Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin\u2019s disease: implications for lineage determination and differential diagnosis. Proc Natl Acad Sci USA. 1986; 83: 7942-7946.","DOI":"10.1073\/pnas.83.20.7942"},{"key":"6","unstructured":"6 Raghavachar A, Binder T, Bartram CR. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin\u2019s disease. Cancer Res. 1988; 48: 3591-3594."},{"key":"7","unstructured":"7 Lin SH, Yeh HM, Tzeng CH, Chen PM. Immunoglobulin and T cell receptor beta chain gene rearrangements and Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease in Taiwan. Int J Hematol. 1993; 57: 251-257."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 van Dongen JJ, Langerak AW, Br\u00fcggemann M <i>et al.<\/i> Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17: 2257-2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Br\u00fcggemann M, White H, Gaulard P <i>et al.<\/i> Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia. 2007; 21: 215-221.","DOI":"10.1038\/sj.leu.2404481"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Miyata-Takata T, Takata K, Yamanouchi S <i>et al.<\/i> Detection of T-cell receptor \u03b3 gene rearrangement in paraffin-embedded T or natural killer\/T-cell lymphoma samples using the BIOMED-2 protocol. Leuk Lymphoma. 2014; 55: 2161-2164.","DOI":"10.3109\/10428194.2013.871634"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Han S, Masaki A, Sakamoto Y <i>et al.<\/i> Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue study. Pathol Int. 2018; 68: 287-293.","DOI":"10.1111\/pin.12660"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ghorbian S, Jahanzad I, Javadi GR, Sakhinia E. Evaluation of IGK and IGL molecular gene rearrangements according to the BIOMED-2 protocols for clinical diagnosis of Hodgkin lymphoma. Hematology. 2016; 21: 133-137.","DOI":"10.1179\/1607845415Y.0000000035"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Venkataraman G, Song JY, Tzankov A <i>et al.<\/i> Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013; 121: 1795-1804.","DOI":"10.1182\/blood-2012-06-439455"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Tzankov A, Bourgau C, Kaiser A <i>et al.<\/i> Rare expression of T-cell markers in classical Hodgkin\u2019s lymphoma. Mod Pathol. 2005; 18: 1542-1549.","DOI":"10.1038\/modpathol.3800473"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Shin S, Kim AH, Park J <i>et al.<\/i> Analysis of immunoglobulin and T cell receptor gene rearrangement in the bone marrow of lymphoid neoplasia using BIOMED-2 multiplex polymerase chain reaction. Int J Med Sci. 2013; 10: 1510-1517.","DOI":"10.7150\/ijms.5342"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ohnishi N, Takata K, Miyata-Takata T <i>et al.<\/i> CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine. Cancer Sci. 2016; 107: 1687-1695.","DOI":"10.1111\/cas.13031"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Takata K, Saito K, Maruyama S <i>et al.<\/i> Identification of TRA-1-60-positive cells as a potent refractory population in follicular lymphomas. Cancer Sci. 2019; 110: 443-457.","DOI":"10.1111\/cas.13870"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Russell J, Collins A, Fowler A <i>et al.<\/i> Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial. Ann Hematol. 2021; 100: 1049-1058.","DOI":"10.1007\/s00277-021-04460-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Naresh KN, Menasce LP, Shenjere P, Banerjee SS. \u2018Precursors\u2019 of classical Hodgkin lymphoma in samples of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2008; 141: 124-126.","DOI":"10.1111\/j.1365-2141.2008.07004.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Attygalle AD, Chan JKC, Coupland SE, <i>et al.<\/i> The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update. Leuk Lymphoma. 2024; 65: 413-429.","DOI":"10.1080\/10428194.2023.2297939"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Asano N, Kinoshita T, Tamaru J <i>et al.<\/i> Cytotoxic molecule-positive classical Hodgkin\u2019s lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type. Haematologica. 2011; 96: 1636-1643.","DOI":"10.3324\/haematol.2011.041079"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Asano N, Oshiro A, Matsuo K <i>et al.<\/i> Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin\u2019s lymphoma: a clinicopathologic study. J Clin Oncol. 2006; 24: 4626-4633.","DOI":"10.1200\/JCO.2006.06.5342"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/2\/64_24027\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T04:51:52Z","timestamp":1719636712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/2\/64_24027\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24027","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24027"}}